Shefali Agarwal

2019

In 2019, Shefali Agarwal earned a total compensation of $2.9M as Chief Medical Officer at Epizyme, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$265,122
Option Awards$1,255,325
Salary$463,500
Stock Awards$894,607
Other$8,652
Total$2,887,206

Agarwal received $1.3M in option awards, accounting for 43% of the total pay in 2019.

Agarwal also received $265.1K in non-equity incentive plan, $463.5K in salary, $894.6K in stock awards and $8.7K in other compensation.

Rankings

In 2019, Shefali Agarwal's compensation ranked 4,243rd out of 13,971 executives tracked by ExecPay. In other words, Agarwal earned more than 69.6% of executives.

ClassificationRankingPercentile
All
4,243
out of 13,971
70th
Division
Manufacturing
1,553
out of 5,695
73rd
Major group
Chemicals And Allied Products
544
out of 2,194
75th
Industry group
Drugs
456
out of 1,880
76th
Industry
Pharmaceutical Preparations
349
out of 1,392
75th

Pay ratio

Shefali Agarwal's Pay$2,887,206
Median Employee's Pay$302,723
Pay Ratio

10

to 1

In 2019, the annual total compensation of Shefali Agarwal was $2,887,206.

The annual total compensation of the median employee at Epizyme was $302,723.

The ratio of Shefali Agarwal's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 17, 2020.

Agarwal's colleagues

We found four more compensation records of executives who worked with Shefali Agarwal at Epizyme in 2019.

2019

Robert Bazemore

Epizyme

Chief Executive Officer

2019

Paolo Tombesi

Epizyme

Chief Financial Officer

2019

Matthew Ros

Epizyme

Chief Strategy and Business Officer

2019

Suzanne Fleming

Epizyme

Former Senior Vice President, Finance and Treasurer

News

You may also like